MEK inhibition enhances efficacy of bacillus Calmette-Guérin on bladder cancer cells by reducing release of Toll-like receptor 2-activated antimicrobial peptides

Bacillus Calmette-Guérin (BCG) is one of the standard treatment options for non-muscle-invasive bladder cancer. The details of the biological defense mechanisms against BCG remain unclear. Here, we investigated whether BCG-induced release of antimicrobial peptides (AMPs; e.g., human β-defensin-2, -3...

Descripción completa

Detalles Bibliográficos
Autores principales: Whang, Young Mi, Jin, Su Bin, Park, Serk In, Chang, In Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581101/
https://www.ncbi.nlm.nih.gov/pubmed/28881802
http://dx.doi.org/10.18632/oncotarget.18230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581101/
https://www.ncbi.nlm.nih.gov/pubmed/28881802
http://dx.doi.org/10.18632/oncotarget.18230

Ejemplares similares